PLoS ONE, ISSN 1932-6203, 10/2019, Volume 14, Issue 10, p. e0224116
Liver transplant (LT) programs in Germany increasingly face a multiethnic patient population. To date no outcome data for LT in patients with a history of...
Transplantation | Demographic aspects | Immigrants | Health aspects | Liver | Patient outcomes | Aliens | Transplants & implants | Syngeneic grafts | Decision making | Immigration policy | Migration | Citizenship | Multivariate analysis | Decision analysis | Minority & ethnic groups | Patients | Success | Intercultural communication | Hepatitis | Allografts | Surgery | Population | Comparative analysis | Public health | Liver transplantation
Transplantation | Demographic aspects | Immigrants | Health aspects | Liver | Patient outcomes | Aliens | Transplants & implants | Syngeneic grafts | Decision making | Immigration policy | Migration | Citizenship | Multivariate analysis | Decision analysis | Minority & ethnic groups | Patients | Success | Intercultural communication | Hepatitis | Allografts | Surgery | Population | Comparative analysis | Public health | Liver transplantation
Journal Article
Deutsches Arzteblatt International, ISSN 1866-0452, 08/2017, Volume 114, Issue 31-32, pp. 519 - 526
Background: Hepatocellular carcinoma (HCC) has an incidence of 5-10 per 100 000 persons per year in the Western world. In 20% of cases, surgical liver...
RETROSPECTIVE-ANALYSIS | MEDICINE, GENERAL & INTERNAL | LIVER-TRANSPLANTATION | MANAGEMENT | TO-TREAT ANALYSIS | LONG-TERM OUTCOMES | CHILD-PUGH | CIRRHOTIC-PATIENTS | SURGICAL-TREATMENT | HEPATIC RESECTION | MILAN CRITERIA | Original
RETROSPECTIVE-ANALYSIS | MEDICINE, GENERAL & INTERNAL | LIVER-TRANSPLANTATION | MANAGEMENT | TO-TREAT ANALYSIS | LONG-TERM OUTCOMES | CHILD-PUGH | CIRRHOTIC-PATIENTS | SURGICAL-TREATMENT | HEPATIC RESECTION | MILAN CRITERIA | Original
Journal Article
Cancers, ISSN 2072-6694, 10/2018, Volume 10, Issue 10, p. 389
Liver resection is a curative treatment for hepatocellular carcinoma (HCC). Tumor-infiltrating leukocytes (TILs) are important players in predicting HCC...
Hepatocellular carcinoma | Tumor-infiltrating leukocytes | Immunology | Liver resection | Quantification of the tumor immune stroma (QTiS) | SURVIVAL | LIVER-TRANSPLANTATION | METAANALYSIS | ANGIOGENESIS | IMMUNOSCORE | RATIO | CD8(+) T-CELLS | BREAST-CANCER | liver resection | ONCOLOGY | RECURRENCE | quantification of the tumor immune stroma (QTiS) | immunology | tumor-infiltrating leukocytes | hepatocellular carcinoma | LYMPHOCYTE INFILTRATION | Immunohistochemistry | Leukocyte migration | Transplants & implants | Disease | CD8 antigen | Invasiveness | Neutrophils | Stroma | CD3 antigen | Family medical history | Cancer therapies | Patients | Metastases | Studies | Liver cancer | Hepatitis | Lymphocytes | Medical prognosis | Surgery | CD20 antigen | Cell migration | Tumors
Hepatocellular carcinoma | Tumor-infiltrating leukocytes | Immunology | Liver resection | Quantification of the tumor immune stroma (QTiS) | SURVIVAL | LIVER-TRANSPLANTATION | METAANALYSIS | ANGIOGENESIS | IMMUNOSCORE | RATIO | CD8(+) T-CELLS | BREAST-CANCER | liver resection | ONCOLOGY | RECURRENCE | quantification of the tumor immune stroma (QTiS) | immunology | tumor-infiltrating leukocytes | hepatocellular carcinoma | LYMPHOCYTE INFILTRATION | Immunohistochemistry | Leukocyte migration | Transplants & implants | Disease | CD8 antigen | Invasiveness | Neutrophils | Stroma | CD3 antigen | Family medical history | Cancer therapies | Patients | Metastases | Studies | Liver cancer | Hepatitis | Lymphocytes | Medical prognosis | Surgery | CD20 antigen | Cell migration | Tumors
Journal Article
World Journal of Surgery, ISSN 0364-2313, 12/2016, Volume 40, Issue 12, pp. 2988 - 2998
The value of temporary intraoperative porto-caval shunts (TPCS) in cava-sparing liver transplantation is discussed controversially. Aim of this meta-analysis...
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | ALLOGRAFT | VENA-CAVA PRESERVATION | INJURY | RISK | GRAFT | RECIPIENTS | FLOW | Kidney - physiology | Length of Stay | Blood Loss, Surgical - prevention & control | Liver Transplantation - methods | Aspartate Aminotransferases - blood | Erythrocyte Transfusion | Intraoperative Care - methods | Humans | Postoperative Period | Portacaval Shunt, Surgical | Transplantation | Biological products | Analysis | Liver
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | ALLOGRAFT | VENA-CAVA PRESERVATION | INJURY | RISK | GRAFT | RECIPIENTS | FLOW | Kidney - physiology | Length of Stay | Blood Loss, Surgical - prevention & control | Liver Transplantation - methods | Aspartate Aminotransferases - blood | Erythrocyte Transfusion | Intraoperative Care - methods | Humans | Postoperative Period | Portacaval Shunt, Surgical | Transplantation | Biological products | Analysis | Liver
Journal Article
Surgical Oncology, ISSN 0960-7404, 12/2018, Volume 27, Issue 4, pp. 663 - 673
To develop criteria for safe and oncologically satisfying liver resection in case of early hepatocellular carcinoma with a 5-year overall survival (OS) similar...
Liver function | Risk-stratification | Oncology | Liver resection | Tumor immunology | LONG-TERM | SURVIVAL | SURGERY | DIAGNOSIS | MILAN CRITERIA | TRANSPLANTATION | PROGNOSTIC-FACTOR | CIRRHOSIS | T-CELLS | SEVERITY | Follow-Up Studies | Humans | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Liver Transplantation - mortality | Male | Survival Rate | Treatment Outcome | Hepatectomy - mortality | Carcinoma, Hepatocellular - pathology | Female | Liver Neoplasms - pathology | Aged | Retrospective Studies | Research Design | Transplantation of organs, tissues, etc | Hepatoma | Liver cirrhosis | Liver | Analysis | Hypertension | Transplants & implants | Syngeneic grafts | Values | Hepatocellular carcinoma | Transplantation | Interdisciplinary aspects | Criteria | Patients | Survival | Subgroups | Confidence intervals | Liver cancer | Cirrhosis | Biological effects | Immunology | Salvage | Allografts | Medical prognosis | Population | Liver transplantation | Tumors
Liver function | Risk-stratification | Oncology | Liver resection | Tumor immunology | LONG-TERM | SURVIVAL | SURGERY | DIAGNOSIS | MILAN CRITERIA | TRANSPLANTATION | PROGNOSTIC-FACTOR | CIRRHOSIS | T-CELLS | SEVERITY | Follow-Up Studies | Humans | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Liver Transplantation - mortality | Male | Survival Rate | Treatment Outcome | Hepatectomy - mortality | Carcinoma, Hepatocellular - pathology | Female | Liver Neoplasms - pathology | Aged | Retrospective Studies | Research Design | Transplantation of organs, tissues, etc | Hepatoma | Liver cirrhosis | Liver | Analysis | Hypertension | Transplants & implants | Syngeneic grafts | Values | Hepatocellular carcinoma | Transplantation | Interdisciplinary aspects | Criteria | Patients | Survival | Subgroups | Confidence intervals | Liver cancer | Cirrhosis | Biological effects | Immunology | Salvage | Allografts | Medical prognosis | Population | Liver transplantation | Tumors
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2002, Volume 8, Issue 2, pp. 128 - 135
Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are...
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | ANGIOGENESIS | MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CELL BIOLOGY | SIGNAL-TRANSDUCTION | LIVER METASTASES | IN-VITRO | CYCLOSPORINE-A | CARCINOMA | PROGRESSION | Vascular Endothelial Growth Factor A | Sirolimus - therapeutic use | Vascular Endothelial Growth Factors | Lymphokines - physiology | Adenocarcinoma - drug therapy | Adenocarcinoma - blood supply | Animals | Antibiotics, Antineoplastic - therapeutic use | Neoplasm Metastasis - prevention & control | Angiogenesis Inhibitors - therapeutic use | Neovascularization, Pathologic - prevention & control | Mice | Mice, Inbred BALB C | Endothelial Growth Factors - physiology
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | ANGIOGENESIS | MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CELL BIOLOGY | SIGNAL-TRANSDUCTION | LIVER METASTASES | IN-VITRO | CYCLOSPORINE-A | CARCINOMA | PROGRESSION | Vascular Endothelial Growth Factor A | Sirolimus - therapeutic use | Vascular Endothelial Growth Factors | Lymphokines - physiology | Adenocarcinoma - drug therapy | Adenocarcinoma - blood supply | Animals | Antibiotics, Antineoplastic - therapeutic use | Neoplasm Metastasis - prevention & control | Angiogenesis Inhibitors - therapeutic use | Neovascularization, Pathologic - prevention & control | Mice | Mice, Inbred BALB C | Endothelial Growth Factors - physiology
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2018, Volume 13, Issue 4, p. e0194975
Background mTOR-Is positively influence the occurrence and course of certain tumors after solid organ transplantation. The effect of mTOR-Is on the overall...
MAMMALIAN TARGET | HEPATOCELLULAR-CARCINOMA | KIDNEY-TRANSPLANTATION | RAPAMYCIN INHIBITORS | AUSTRALIAN LIVER | MULTIDISCIPLINARY SCIENCES | CANCER INCIDENCE | REDUCED-EXPOSURE | MYCOPHENOLATE-MOFETIL | SKIN-CANCER | CLINICAL-OUTCOMES | Complications and side effects | Kidneys | Mortality | Analysis | Transplantation | Research | Risk factors | Cancer | Meta-analysis | TOR protein | Transplants & implants | Clinical trials | Systematic review | Malignancy | Patients | Survival | Incidence | Liver cancer | Randomization | Surgery | Health risk assessment | Tumors | Kidney transplantation
MAMMALIAN TARGET | HEPATOCELLULAR-CARCINOMA | KIDNEY-TRANSPLANTATION | RAPAMYCIN INHIBITORS | AUSTRALIAN LIVER | MULTIDISCIPLINARY SCIENCES | CANCER INCIDENCE | REDUCED-EXPOSURE | MYCOPHENOLATE-MOFETIL | SKIN-CANCER | CLINICAL-OUTCOMES | Complications and side effects | Kidneys | Mortality | Analysis | Transplantation | Research | Risk factors | Cancer | Meta-analysis | TOR protein | Transplants & implants | Clinical trials | Systematic review | Malignancy | Patients | Survival | Incidence | Liver cancer | Randomization | Surgery | Health risk assessment | Tumors | Kidney transplantation
Journal Article
Transplantation Research, ISSN 2047-1440, 2014, Volume 3, Issue 1, pp. 6 - 6
Journal Article
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, ISSN 0044-409X, 08/2018, Volume 143, Issue 4, pp. 433 - 441
Zusammenfassung Das Transplantationsgesetz (TPG) als Rechtsgrundlage für das Verteilungssystem in der Lebertransplantation in Deutschland wird durch...
Originalarbeit
Originalarbeit
Journal Article
Transplant International, ISSN 0934-0874, 10/2013, Volume 26, Issue 10, pp. 999 - 1006
Summary De novo malignancies are a major cause of late death after liver transplantation. Aim of the present study was to determine whether use of cyclosporine...
risk factors | calcineurin inhibitor | immunosuppression | cancer development | multivariate analysis | liver transplantation | long‐term survival | long-term survival | SURGERY | GRAFT RECIPIENTS | RISK-FACTORS | INHIBITOR-FREE IMMUNOSUPPRESSION | CANCER | ORGAN | TRANSPLANTATION | MTOR INHIBITION | KIDNEY-TRANSPLANTATION | REGISTRY | Liver Failure - complications | Multivariate Analysis | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Treatment Outcome | Incidence | Cyclosporine - therapeutic use | Liver Transplantation - methods | Neoplasms - complications | Tacrolimus - therapeutic use | Immunosuppression | Liver Failure - therapy | Neoplasms - immunology | Sex Factors | Adult | Female | Neoplasms - epidemiology | Tacrolimus | Analysis | Lung cancer | Immunotherapy | Liver | Melanoma | Organ transplant recipients | Transplantation | Cyclosporine | Cancer
risk factors | calcineurin inhibitor | immunosuppression | cancer development | multivariate analysis | liver transplantation | long‐term survival | long-term survival | SURGERY | GRAFT RECIPIENTS | RISK-FACTORS | INHIBITOR-FREE IMMUNOSUPPRESSION | CANCER | ORGAN | TRANSPLANTATION | MTOR INHIBITION | KIDNEY-TRANSPLANTATION | REGISTRY | Liver Failure - complications | Multivariate Analysis | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Treatment Outcome | Incidence | Cyclosporine - therapeutic use | Liver Transplantation - methods | Neoplasms - complications | Tacrolimus - therapeutic use | Immunosuppression | Liver Failure - therapy | Neoplasms - immunology | Sex Factors | Adult | Female | Neoplasms - epidemiology | Tacrolimus | Analysis | Lung cancer | Immunotherapy | Liver | Melanoma | Organ transplant recipients | Transplantation | Cyclosporine | Cancer
Journal Article
Heilberufe, ISSN 0017-9604, 04/2016, Volume 68, Issue 4, pp. 28 - 30
Journal Article
Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie, ISSN 0044-409X, 2018, Volume 143, Issue 4, pp. 433 - 441
Journal Article
MMW-Fortschritte der Medizin, ISSN 1438-3276, 05/2015, Volume 157, Issue 10, pp. 48 - 49
Journal Article
Oxidative Medicine and Cellular Longevity, ISSN 1942-0900, 2017, Volume 2017, pp. 8325754 - 12
Background. Reactive oxygen species-(ROS-) mediated ischemia-reperfusion injury (IRI) detrimentally impacts liver transplantation and resection....
RAT-LIVER | OXIDATIVE STRESS | ISCHEMIA/REPERFUSION INJURY | LIVER-TRANSPLANTATION | COLD ISCHEMIA | WARM ISCHEMIA | SCUTELLARIA-BAICALENSIS | FERROPTOSIS | DIMETHYL-SULFOXIDE | MOLECULAR-MECHANISMS | CELL BIOLOGY | Reactive Oxygen Species - metabolism | Arachidonate 12-Lipoxygenase - metabolism | Apoptosis - drug effects | Glutathione - metabolism | Arachidonate 12-Lipoxygenase - chemistry | Arachidonate 15-Lipoxygenase - chemistry | Dimethyl Sulfoxide - pharmacology | Male | Alanine Transaminase - blood | Flavanones - toxicity | Liver - drug effects | Reperfusion Injury - metabolism | Ischemia - pathology | Glutathione Peroxidase - metabolism | Reperfusion Injury - pathology | Liver - metabolism | Mice, Inbred C57BL | Ischemia - metabolism | Poly (ADP-Ribose) Polymerase-1 - metabolism | Arachidonate 15-Lipoxygenase - metabolism | Down-Regulation - drug effects | Animals | Aspartate Aminotransferases - blood | Hemodynamics - drug effects | Mice | Mitogen-Activated Protein Kinases - metabolism | Reactive oxygen species | Cellular signal transduction | Research | Ischemia | Glutathione | Oxidative stress | Transplants & implants | Pulmonary arteries | Liver | Lipid peroxidation | Cytotoxicity | Lipids | Kinases | Experiments | Medicine | Studies | Antioxidants | Signal transduction | Toxicology | Rodents | Gangrene | Apoptosis
RAT-LIVER | OXIDATIVE STRESS | ISCHEMIA/REPERFUSION INJURY | LIVER-TRANSPLANTATION | COLD ISCHEMIA | WARM ISCHEMIA | SCUTELLARIA-BAICALENSIS | FERROPTOSIS | DIMETHYL-SULFOXIDE | MOLECULAR-MECHANISMS | CELL BIOLOGY | Reactive Oxygen Species - metabolism | Arachidonate 12-Lipoxygenase - metabolism | Apoptosis - drug effects | Glutathione - metabolism | Arachidonate 12-Lipoxygenase - chemistry | Arachidonate 15-Lipoxygenase - chemistry | Dimethyl Sulfoxide - pharmacology | Male | Alanine Transaminase - blood | Flavanones - toxicity | Liver - drug effects | Reperfusion Injury - metabolism | Ischemia - pathology | Glutathione Peroxidase - metabolism | Reperfusion Injury - pathology | Liver - metabolism | Mice, Inbred C57BL | Ischemia - metabolism | Poly (ADP-Ribose) Polymerase-1 - metabolism | Arachidonate 15-Lipoxygenase - metabolism | Down-Regulation - drug effects | Animals | Aspartate Aminotransferases - blood | Hemodynamics - drug effects | Mice | Mitogen-Activated Protein Kinases - metabolism | Reactive oxygen species | Cellular signal transduction | Research | Ischemia | Glutathione | Oxidative stress | Transplants & implants | Pulmonary arteries | Liver | Lipid peroxidation | Cytotoxicity | Lipids | Kinases | Experiments | Medicine | Studies | Antioxidants | Signal transduction | Toxicology | Rodents | Gangrene | Apoptosis
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 6/2016, Volume 20, Issue 6, pp. 1163 - 1172
The continuing controversy about surgery for non-colorectal non-neuroendocrine liver metastases (NCRNNE) necessitates identifying risk factors of worsened...
Liver resection | Medicine & Public Health | Renal cell carcinoma | Surgery | Gastroenterology | Non-neuroendocrine | Non-colorectal | Metastasis | SURVIVAL | SURGERY | HEPATECTOMY | NONNEUROENDOCRINE METASTASES | HEPATIC RESECTION | TUMORS | NONCOLORECTAL PRIMARY | GASTRIC-CANCER | EXPERIENCE | SURGICAL RESECTION | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | Hepatectomy - adverse effects | Humans | Middle Aged | Liver Neoplasms - surgery | Male | Survival Rate | Tumor Burden | Patient Selection | Neoplasm, Residual | Young Adult | Disease-Free Survival | Carcinoma, Renal Cell - secondary | Adolescent | Aged, 80 and over | Adult | Female | Kidney Neoplasms - pathology | Aged | Retrospective Studies | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Comparative analysis | Epidemiology | Liver | Colorectal cancer
Liver resection | Medicine & Public Health | Renal cell carcinoma | Surgery | Gastroenterology | Non-neuroendocrine | Non-colorectal | Metastasis | SURVIVAL | SURGERY | HEPATECTOMY | NONNEUROENDOCRINE METASTASES | HEPATIC RESECTION | TUMORS | NONCOLORECTAL PRIMARY | GASTRIC-CANCER | EXPERIENCE | SURGICAL RESECTION | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | Hepatectomy - adverse effects | Humans | Middle Aged | Liver Neoplasms - surgery | Male | Survival Rate | Tumor Burden | Patient Selection | Neoplasm, Residual | Young Adult | Disease-Free Survival | Carcinoma, Renal Cell - secondary | Adolescent | Aged, 80 and over | Adult | Female | Kidney Neoplasms - pathology | Aged | Retrospective Studies | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Comparative analysis | Epidemiology | Liver | Colorectal cancer
Journal Article
Annals of Surgery, ISSN 0003-4932, 01/2011, Volume 253, Issue 1, pp. 166 - 172
Background: Liberal acceptance criteria are used when offering liver transplantation (LTx) for treatment of hepatocellular carcinoma (HCC) at our center. This...
MICROVASCULAR INVASION | STAGING SYSTEM | SURGERY | HISTOLOGICAL GRADE | HCC PATIENTS | INTENTION-TO-TREAT | VASCULAR INVASION | SELECTION CRITERIA | RECURRENCE | MILAN CRITERIA | SURGICAL-TREATMENT | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Liver Transplantation | Neoplasm Invasiveness | Humans | Middle Aged | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Survival Rate | Liver Neoplasms - mortality | Patient Selection | Young Adult | Biopsy | Carcinoma, Hepatocellular - pathology | Adult | Female | Liver Neoplasms - pathology | Aged | Retrospective Studies | Neoplasm Staging | Cohort Studies
MICROVASCULAR INVASION | STAGING SYSTEM | SURGERY | HISTOLOGICAL GRADE | HCC PATIENTS | INTENTION-TO-TREAT | VASCULAR INVASION | SELECTION CRITERIA | RECURRENCE | MILAN CRITERIA | SURGICAL-TREATMENT | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Liver Transplantation | Neoplasm Invasiveness | Humans | Middle Aged | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Survival Rate | Liver Neoplasms - mortality | Patient Selection | Young Adult | Biopsy | Carcinoma, Hepatocellular - pathology | Adult | Female | Liver Neoplasms - pathology | Aged | Retrospective Studies | Neoplasm Staging | Cohort Studies
Journal Article
Zentralblatt fur Chirurgie, 08/2018, Volume 143, Issue 4, p. 433
The German Transplant Law is the legal basis of the liver allocation system in Germany and is specified by the guidelines of the German Medical Association....
Attitude of Health Personnel | Liver Transplantation | Guideline Adherence | Humans | Tissue and Organ Procurement | Waiting Lists | Health Knowledge, Attitudes, Practice | Germany
Attitude of Health Personnel | Liver Transplantation | Guideline Adherence | Humans | Tissue and Organ Procurement | Waiting Lists | Health Knowledge, Attitudes, Practice | Germany
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2019, Volume 19, Issue 1, pp. 575 - 8
BackgroundDistant metastases frequently occur in gastroenteropancreatic neuroendocrine tumors. If hepatic surgery is not feasible, patients are treated with...
Intra-individual | microRNA | Somatostatin | Neuroendocrine tumor | MANAGEMENT | NEOPLASMS | ENETS CONSENSUS GUIDELINES | ENDOCRINE | MIRNA EXPRESSION | ONCOLOGY | COLORECTAL-CANCER | MICRORNA EXPRESSION | LANREOTIDE | Medicine, Experimental | Medical research | Research | Gene expression
Intra-individual | microRNA | Somatostatin | Neuroendocrine tumor | MANAGEMENT | NEOPLASMS | ENETS CONSENSUS GUIDELINES | ENDOCRINE | MIRNA EXPRESSION | ONCOLOGY | COLORECTAL-CANCER | MICRORNA EXPRESSION | LANREOTIDE | Medicine, Experimental | Medical research | Research | Gene expression
Journal Article